Regulatory T cell therapy for uveitis
Acta Ophthalmologica, 08/08/2012
Bodaghi B – Tolerance and efficacy will be monitored with clinical examination, laser flare photometry and imaging. Intraocular levels of pro and anti–inflammatory cytokines will be determined in each patient at baseline and after T–reg administration. Cell therapy may become an interesting strategy, expanding the anti–inflammatory armamentarium.